Global Psoriasis Treatment Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Psoriasis Treatment Drugs market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Psoriasis Treatment Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Psoriasis Treatment Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Psoriasis Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Psoriasis Treatment Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Psoriasis Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Psoriasis Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psoriasis Treatment Drugs, with revenue, gross margin, and global market share of Psoriasis Treatment Drugs from 2020 to 2025.
Chapter 3, the Psoriasis Treatment Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Psoriasis Treatment Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriasis Treatment Drugs.
Chapter 13, to describe Psoriasis Treatment Drugs research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Psoriasis Treatment Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Psoriasis Treatment Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Psoriasis Treatment Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Psoriasis Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Psoriasis Treatment Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Psoriasis Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- TNF Inhibitors
- Interleukin Inhibitors
- Vitamin D Analogs
- Corticosteroids
- Others
- Oral
- Parenteral
- Topical
- Amgen
- Allergan
- Dermira
- Eli Lilly
- Novartis
- Merck
- Johnson & Johnson
- Pfizer
- AstraZeneca
- AbbVie
- LEO Pharma
- Biogen
- Galectin Therapeutics
- Cellceutix
- Bayer
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Psoriasis Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psoriasis Treatment Drugs, with revenue, gross margin, and global market share of Psoriasis Treatment Drugs from 2020 to 2025.
Chapter 3, the Psoriasis Treatment Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Psoriasis Treatment Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriasis Treatment Drugs.
Chapter 13, to describe Psoriasis Treatment Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Psoriasis Treatment Drugs by Type
1.3.1 Overview: Global Psoriasis Treatment Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Psoriasis Treatment Drugs Consumption Value Market Share by Type in 2024
1.3.3 TNF Inhibitors
1.3.4 Interleukin Inhibitors
1.3.5 Vitamin D Analogs
1.3.6 Corticosteroids
1.3.7 Others
1.4 Global Psoriasis Treatment Drugs Market by Application
1.4.1 Overview: Global Psoriasis Treatment Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oral
1.4.3 Parenteral
1.4.4 Topical
1.5 Global Psoriasis Treatment Drugs Market Size & Forecast
1.6 Global Psoriasis Treatment Drugs Market Size and Forecast by Region
1.6.1 Global Psoriasis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Psoriasis Treatment Drugs Market Size by Region, (2020-2031)
1.6.3 North America Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.4 Europe Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.6 South America Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Psoriasis Treatment Drugs Product and Solutions
2.1.4 Amgen Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Psoriasis Treatment Drugs Product and Solutions
2.2.4 Allergan Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Dermira
2.3.1 Dermira Details
2.3.2 Dermira Major Business
2.3.3 Dermira Psoriasis Treatment Drugs Product and Solutions
2.3.4 Dermira Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Dermira Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Psoriasis Treatment Drugs Product and Solutions
2.4.4 Eli Lilly Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Psoriasis Treatment Drugs Product and Solutions
2.5.4 Novartis Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Psoriasis Treatment Drugs Product and Solutions
2.6.4 Merck Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Merck Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Psoriasis Treatment Drugs Product and Solutions
2.7.4 Johnson & Johnson Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Psoriasis Treatment Drugs Product and Solutions
2.8.4 Pfizer Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Psoriasis Treatment Drugs Product and Solutions
2.9.4 AstraZeneca Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 AstraZeneca Recent Developments and Future Plans
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Psoriasis Treatment Drugs Product and Solutions
2.10.4 AbbVie Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 AbbVie Recent Developments and Future Plans
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Psoriasis Treatment Drugs Product and Solutions
2.11.4 LEO Pharma Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 LEO Pharma Recent Developments and Future Plans
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Psoriasis Treatment Drugs Product and Solutions
2.12.4 Biogen Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biogen Recent Developments and Future Plans
2.13 Galectin Therapeutics
2.13.1 Galectin Therapeutics Details
2.13.2 Galectin Therapeutics Major Business
2.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Product and Solutions
2.13.4 Galectin Therapeutics Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Galectin Therapeutics Recent Developments and Future Plans
2.14 Cellceutix
2.14.1 Cellceutix Details
2.14.2 Cellceutix Major Business
2.14.3 Cellceutix Psoriasis Treatment Drugs Product and Solutions
2.14.4 Cellceutix Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Cellceutix Recent Developments and Future Plans
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Psoriasis Treatment Drugs Product and Solutions
2.15.4 Bayer Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Bayer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Psoriasis Treatment Drugs Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Psoriasis Treatment Drugs by Company Revenue
3.2.2 Top 3 Psoriasis Treatment Drugs Players Market Share in 2024
3.2.3 Top 6 Psoriasis Treatment Drugs Players Market Share in 2024
3.3 Psoriasis Treatment Drugs Market: Overall Company Footprint Analysis
3.3.1 Psoriasis Treatment Drugs Market: Region Footprint
3.3.2 Psoriasis Treatment Drugs Market: Company Product Type Footprint
3.3.3 Psoriasis Treatment Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Psoriasis Treatment Drugs Consumption Value and Market Share by Type (2020-2025)
4.2 Global Psoriasis Treatment Drugs Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2025)
5.2 Global Psoriasis Treatment Drugs Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
6.2 North America Psoriasis Treatment Drugs Market Size by Application (2020-2031)
6.3 North America Psoriasis Treatment Drugs Market Size by Country
6.3.1 North America Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
6.3.3 Canada Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
6.3.4 Mexico Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
7.2 Europe Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
7.3 Europe Psoriasis Treatment Drugs Market Size by Country
7.3.1 Europe Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.3 France Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.5 Russia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.6 Italy Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region
8.3.1 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2020-2031)
8.3.2 China Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.3 Japan Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.4 South Korea Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.5 India Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.7 Australia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
9.2 South America Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
9.3 South America Psoriasis Treatment Drugs Market Size by Country
9.3.1 South America Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
9.3.3 Argentina Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country
10.3.1 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10.3.4 UAE Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Psoriasis Treatment Drugs Market Drivers
11.2 Psoriasis Treatment Drugs Market Restraints
11.3 Psoriasis Treatment Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Psoriasis Treatment Drugs Industry Chain
12.2 Psoriasis Treatment Drugs Upstream Analysis
12.3 Psoriasis Treatment Drugs Midstream Analysis
12.4 Psoriasis Treatment Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Psoriasis Treatment Drugs by Type
1.3.1 Overview: Global Psoriasis Treatment Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Psoriasis Treatment Drugs Consumption Value Market Share by Type in 2024
1.3.3 TNF Inhibitors
1.3.4 Interleukin Inhibitors
1.3.5 Vitamin D Analogs
1.3.6 Corticosteroids
1.3.7 Others
1.4 Global Psoriasis Treatment Drugs Market by Application
1.4.1 Overview: Global Psoriasis Treatment Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oral
1.4.3 Parenteral
1.4.4 Topical
1.5 Global Psoriasis Treatment Drugs Market Size & Forecast
1.6 Global Psoriasis Treatment Drugs Market Size and Forecast by Region
1.6.1 Global Psoriasis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Psoriasis Treatment Drugs Market Size by Region, (2020-2031)
1.6.3 North America Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.4 Europe Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.6 South America Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Psoriasis Treatment Drugs Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Psoriasis Treatment Drugs Product and Solutions
2.1.4 Amgen Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Psoriasis Treatment Drugs Product and Solutions
2.2.4 Allergan Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Dermira
2.3.1 Dermira Details
2.3.2 Dermira Major Business
2.3.3 Dermira Psoriasis Treatment Drugs Product and Solutions
2.3.4 Dermira Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Dermira Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Psoriasis Treatment Drugs Product and Solutions
2.4.4 Eli Lilly Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Psoriasis Treatment Drugs Product and Solutions
2.5.4 Novartis Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Psoriasis Treatment Drugs Product and Solutions
2.6.4 Merck Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Merck Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Psoriasis Treatment Drugs Product and Solutions
2.7.4 Johnson & Johnson Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Psoriasis Treatment Drugs Product and Solutions
2.8.4 Pfizer Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Psoriasis Treatment Drugs Product and Solutions
2.9.4 AstraZeneca Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 AstraZeneca Recent Developments and Future Plans
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Psoriasis Treatment Drugs Product and Solutions
2.10.4 AbbVie Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 AbbVie Recent Developments and Future Plans
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Psoriasis Treatment Drugs Product and Solutions
2.11.4 LEO Pharma Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 LEO Pharma Recent Developments and Future Plans
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Psoriasis Treatment Drugs Product and Solutions
2.12.4 Biogen Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biogen Recent Developments and Future Plans
2.13 Galectin Therapeutics
2.13.1 Galectin Therapeutics Details
2.13.2 Galectin Therapeutics Major Business
2.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Product and Solutions
2.13.4 Galectin Therapeutics Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Galectin Therapeutics Recent Developments and Future Plans
2.14 Cellceutix
2.14.1 Cellceutix Details
2.14.2 Cellceutix Major Business
2.14.3 Cellceutix Psoriasis Treatment Drugs Product and Solutions
2.14.4 Cellceutix Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Cellceutix Recent Developments and Future Plans
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Psoriasis Treatment Drugs Product and Solutions
2.15.4 Bayer Psoriasis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Bayer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Psoriasis Treatment Drugs Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Psoriasis Treatment Drugs by Company Revenue
3.2.2 Top 3 Psoriasis Treatment Drugs Players Market Share in 2024
3.2.3 Top 6 Psoriasis Treatment Drugs Players Market Share in 2024
3.3 Psoriasis Treatment Drugs Market: Overall Company Footprint Analysis
3.3.1 Psoriasis Treatment Drugs Market: Region Footprint
3.3.2 Psoriasis Treatment Drugs Market: Company Product Type Footprint
3.3.3 Psoriasis Treatment Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Psoriasis Treatment Drugs Consumption Value and Market Share by Type (2020-2025)
4.2 Global Psoriasis Treatment Drugs Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2025)
5.2 Global Psoriasis Treatment Drugs Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
6.2 North America Psoriasis Treatment Drugs Market Size by Application (2020-2031)
6.3 North America Psoriasis Treatment Drugs Market Size by Country
6.3.1 North America Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
6.3.3 Canada Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
6.3.4 Mexico Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
7.2 Europe Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
7.3 Europe Psoriasis Treatment Drugs Market Size by Country
7.3.1 Europe Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.3 France Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.5 Russia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
7.3.6 Italy Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region
8.3.1 Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2020-2031)
8.3.2 China Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.3 Japan Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.4 South Korea Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.5 India Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
8.3.7 Australia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
9.2 South America Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
9.3 South America Psoriasis Treatment Drugs Market Size by Country
9.3.1 South America Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
9.3.3 Argentina Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country
10.3.1 Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
10.3.4 UAE Psoriasis Treatment Drugs Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Psoriasis Treatment Drugs Market Drivers
11.2 Psoriasis Treatment Drugs Market Restraints
11.3 Psoriasis Treatment Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Psoriasis Treatment Drugs Industry Chain
12.2 Psoriasis Treatment Drugs Upstream Analysis
12.3 Psoriasis Treatment Drugs Midstream Analysis
12.4 Psoriasis Treatment Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Psoriasis Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Psoriasis Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Psoriasis Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Psoriasis Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Psoriasis Treatment Drugs Product and Solutions
Table 8. Amgen Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Psoriasis Treatment Drugs Product and Solutions
Table 13. Allergan Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Dermira Company Information, Head Office, and Major Competitors
Table 16. Dermira Major Business
Table 17. Dermira Psoriasis Treatment Drugs Product and Solutions
Table 18. Dermira Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Eli Lilly Company Information, Head Office, and Major Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Psoriasis Treatment Drugs Product and Solutions
Table 22. Eli Lilly Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Eli Lilly Recent Developments and Future Plans
Table 24. Novartis Company Information, Head Office, and Major Competitors
Table 25. Novartis Major Business
Table 26. Novartis Psoriasis Treatment Drugs Product and Solutions
Table 27. Novartis Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novartis Recent Developments and Future Plans
Table 29. Merck Company Information, Head Office, and Major Competitors
Table 30. Merck Major Business
Table 31. Merck Psoriasis Treatment Drugs Product and Solutions
Table 32. Merck Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Merck Recent Developments and Future Plans
Table 34. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Psoriasis Treatment Drugs Product and Solutions
Table 37. Johnson & Johnson Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Johnson & Johnson Recent Developments and Future Plans
Table 39. Pfizer Company Information, Head Office, and Major Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Psoriasis Treatment Drugs Product and Solutions
Table 42. Pfizer Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Pfizer Recent Developments and Future Plans
Table 44. AstraZeneca Company Information, Head Office, and Major Competitors
Table 45. AstraZeneca Major Business
Table 46. AstraZeneca Psoriasis Treatment Drugs Product and Solutions
Table 47. AstraZeneca Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Recent Developments and Future Plans
Table 49. AbbVie Company Information, Head Office, and Major Competitors
Table 50. AbbVie Major Business
Table 51. AbbVie Psoriasis Treatment Drugs Product and Solutions
Table 52. AbbVie Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. AbbVie Recent Developments and Future Plans
Table 54. LEO Pharma Company Information, Head Office, and Major Competitors
Table 55. LEO Pharma Major Business
Table 56. LEO Pharma Psoriasis Treatment Drugs Product and Solutions
Table 57. LEO Pharma Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. LEO Pharma Recent Developments and Future Plans
Table 59. Biogen Company Information, Head Office, and Major Competitors
Table 60. Biogen Major Business
Table 61. Biogen Psoriasis Treatment Drugs Product and Solutions
Table 62. Biogen Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Biogen Recent Developments and Future Plans
Table 64. Galectin Therapeutics Company Information, Head Office, and Major Competitors
Table 65. Galectin Therapeutics Major Business
Table 66. Galectin Therapeutics Psoriasis Treatment Drugs Product and Solutions
Table 67. Galectin Therapeutics Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Galectin Therapeutics Recent Developments and Future Plans
Table 69. Cellceutix Company Information, Head Office, and Major Competitors
Table 70. Cellceutix Major Business
Table 71. Cellceutix Psoriasis Treatment Drugs Product and Solutions
Table 72. Cellceutix Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Cellceutix Recent Developments and Future Plans
Table 74. Bayer Company Information, Head Office, and Major Competitors
Table 75. Bayer Major Business
Table 76. Bayer Psoriasis Treatment Drugs Product and Solutions
Table 77. Bayer Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Bayer Recent Developments and Future Plans
Table 79. Global Psoriasis Treatment Drugs Revenue (USD Million) by Players (2020-2025)
Table 80. Global Psoriasis Treatment Drugs Revenue Share by Players (2020-2025)
Table 81. Breakdown of Psoriasis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Psoriasis Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Psoriasis Treatment Drugs Players
Table 84. Psoriasis Treatment Drugs Market: Company Product Type Footprint
Table 85. Psoriasis Treatment Drugs Market: Company Product Application Footprint
Table 86. Psoriasis Treatment Drugs New Market Entrants and Barriers to Market Entry
Table 87. Psoriasis Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Psoriasis Treatment Drugs Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Psoriasis Treatment Drugs Consumption Value Share by Type (2020-2025)
Table 90. Global Psoriasis Treatment Drugs Consumption Value Forecast by Type (2026-2031)
Table 91. Global Psoriasis Treatment Drugs Consumption Value by Application (2020-2025)
Table 92. Global Psoriasis Treatment Drugs Consumption Value Forecast by Application (2026-2031)
Table 93. North America Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Psoriasis Treatment Drugs Upstream (Raw Materials)
Table 124. Global Psoriasis Treatment Drugs Typical Customers
Table 1. Global Psoriasis Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Psoriasis Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Psoriasis Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Psoriasis Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Psoriasis Treatment Drugs Product and Solutions
Table 8. Amgen Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Psoriasis Treatment Drugs Product and Solutions
Table 13. Allergan Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Dermira Company Information, Head Office, and Major Competitors
Table 16. Dermira Major Business
Table 17. Dermira Psoriasis Treatment Drugs Product and Solutions
Table 18. Dermira Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Eli Lilly Company Information, Head Office, and Major Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Psoriasis Treatment Drugs Product and Solutions
Table 22. Eli Lilly Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Eli Lilly Recent Developments and Future Plans
Table 24. Novartis Company Information, Head Office, and Major Competitors
Table 25. Novartis Major Business
Table 26. Novartis Psoriasis Treatment Drugs Product and Solutions
Table 27. Novartis Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novartis Recent Developments and Future Plans
Table 29. Merck Company Information, Head Office, and Major Competitors
Table 30. Merck Major Business
Table 31. Merck Psoriasis Treatment Drugs Product and Solutions
Table 32. Merck Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Merck Recent Developments and Future Plans
Table 34. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Psoriasis Treatment Drugs Product and Solutions
Table 37. Johnson & Johnson Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Johnson & Johnson Recent Developments and Future Plans
Table 39. Pfizer Company Information, Head Office, and Major Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Psoriasis Treatment Drugs Product and Solutions
Table 42. Pfizer Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Pfizer Recent Developments and Future Plans
Table 44. AstraZeneca Company Information, Head Office, and Major Competitors
Table 45. AstraZeneca Major Business
Table 46. AstraZeneca Psoriasis Treatment Drugs Product and Solutions
Table 47. AstraZeneca Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Recent Developments and Future Plans
Table 49. AbbVie Company Information, Head Office, and Major Competitors
Table 50. AbbVie Major Business
Table 51. AbbVie Psoriasis Treatment Drugs Product and Solutions
Table 52. AbbVie Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. AbbVie Recent Developments and Future Plans
Table 54. LEO Pharma Company Information, Head Office, and Major Competitors
Table 55. LEO Pharma Major Business
Table 56. LEO Pharma Psoriasis Treatment Drugs Product and Solutions
Table 57. LEO Pharma Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. LEO Pharma Recent Developments and Future Plans
Table 59. Biogen Company Information, Head Office, and Major Competitors
Table 60. Biogen Major Business
Table 61. Biogen Psoriasis Treatment Drugs Product and Solutions
Table 62. Biogen Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Biogen Recent Developments and Future Plans
Table 64. Galectin Therapeutics Company Information, Head Office, and Major Competitors
Table 65. Galectin Therapeutics Major Business
Table 66. Galectin Therapeutics Psoriasis Treatment Drugs Product and Solutions
Table 67. Galectin Therapeutics Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Galectin Therapeutics Recent Developments and Future Plans
Table 69. Cellceutix Company Information, Head Office, and Major Competitors
Table 70. Cellceutix Major Business
Table 71. Cellceutix Psoriasis Treatment Drugs Product and Solutions
Table 72. Cellceutix Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Cellceutix Recent Developments and Future Plans
Table 74. Bayer Company Information, Head Office, and Major Competitors
Table 75. Bayer Major Business
Table 76. Bayer Psoriasis Treatment Drugs Product and Solutions
Table 77. Bayer Psoriasis Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Bayer Recent Developments and Future Plans
Table 79. Global Psoriasis Treatment Drugs Revenue (USD Million) by Players (2020-2025)
Table 80. Global Psoriasis Treatment Drugs Revenue Share by Players (2020-2025)
Table 81. Breakdown of Psoriasis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Psoriasis Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Psoriasis Treatment Drugs Players
Table 84. Psoriasis Treatment Drugs Market: Company Product Type Footprint
Table 85. Psoriasis Treatment Drugs Market: Company Product Application Footprint
Table 86. Psoriasis Treatment Drugs New Market Entrants and Barriers to Market Entry
Table 87. Psoriasis Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Psoriasis Treatment Drugs Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Psoriasis Treatment Drugs Consumption Value Share by Type (2020-2025)
Table 90. Global Psoriasis Treatment Drugs Consumption Value Forecast by Type (2026-2031)
Table 91. Global Psoriasis Treatment Drugs Consumption Value by Application (2020-2025)
Table 92. Global Psoriasis Treatment Drugs Consumption Value Forecast by Application (2026-2031)
Table 93. North America Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Psoriasis Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Psoriasis Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Psoriasis Treatment Drugs Upstream (Raw Materials)
Table 124. Global Psoriasis Treatment Drugs Typical Customers
LIST OF FIGURES
Figure 1. Psoriasis Treatment Drugs Picture
Figure 2. Global Psoriasis Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Psoriasis Treatment Drugs Consumption Value Market Share by Type in 2024
Figure 4. TNF Inhibitors
Figure 5. Interleukin Inhibitors
Figure 6. Vitamin D Analogs
Figure 7. Corticosteroids
Figure 8. Others
Figure 9. Global Psoriasis Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Psoriasis Treatment Drugs Consumption Value Market Share by Application in 2024
Figure 11. Oral Picture
Figure 12. Parenteral Picture
Figure 13. Topical Picture
Figure 14. Global Psoriasis Treatment Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Psoriasis Treatment Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Psoriasis Treatment Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Psoriasis Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Psoriasis Treatment Drugs Consumption Value Market Share by Region in 2024
Figure 19. North America Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Psoriasis Treatment Drugs Revenue Share by Players in 2024
Figure 26. Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Psoriasis Treatment Drugs by Player Revenue in 2024
Figure 28. Top 3 Psoriasis Treatment Drugs Players Market Share in 2024
Figure 29. Top 6 Psoriasis Treatment Drugs Players Market Share in 2024
Figure 30. Global Psoriasis Treatment Drugs Consumption Value Share by Type (2020-2025)
Figure 31. Global Psoriasis Treatment Drugs Market Share Forecast by Type (2026-2031)
Figure 32. Global Psoriasis Treatment Drugs Consumption Value Share by Application (2020-2025)
Figure 33. Global Psoriasis Treatment Drugs Market Share Forecast by Application (2026-2031)
Figure 34. North America Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 44. France Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 51. China Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 54. India Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 68. Psoriasis Treatment Drugs Market Drivers
Figure 69. Psoriasis Treatment Drugs Market Restraints
Figure 70. Psoriasis Treatment Drugs Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Psoriasis Treatment Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Psoriasis Treatment Drugs Picture
Figure 2. Global Psoriasis Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Psoriasis Treatment Drugs Consumption Value Market Share by Type in 2024
Figure 4. TNF Inhibitors
Figure 5. Interleukin Inhibitors
Figure 6. Vitamin D Analogs
Figure 7. Corticosteroids
Figure 8. Others
Figure 9. Global Psoriasis Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Psoriasis Treatment Drugs Consumption Value Market Share by Application in 2024
Figure 11. Oral Picture
Figure 12. Parenteral Picture
Figure 13. Topical Picture
Figure 14. Global Psoriasis Treatment Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Psoriasis Treatment Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Psoriasis Treatment Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Psoriasis Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Psoriasis Treatment Drugs Consumption Value Market Share by Region in 2024
Figure 19. North America Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Psoriasis Treatment Drugs Revenue Share by Players in 2024
Figure 26. Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Psoriasis Treatment Drugs by Player Revenue in 2024
Figure 28. Top 3 Psoriasis Treatment Drugs Players Market Share in 2024
Figure 29. Top 6 Psoriasis Treatment Drugs Players Market Share in 2024
Figure 30. Global Psoriasis Treatment Drugs Consumption Value Share by Type (2020-2025)
Figure 31. Global Psoriasis Treatment Drugs Market Share Forecast by Type (2026-2031)
Figure 32. Global Psoriasis Treatment Drugs Consumption Value Share by Application (2020-2025)
Figure 33. Global Psoriasis Treatment Drugs Market Share Forecast by Application (2026-2031)
Figure 34. North America Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 44. France Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Psoriasis Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 51. China Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 54. India Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Psoriasis Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Psoriasis Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 68. Psoriasis Treatment Drugs Market Drivers
Figure 69. Psoriasis Treatment Drugs Market Restraints
Figure 70. Psoriasis Treatment Drugs Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Psoriasis Treatment Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
